Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anaphylactic Shock Therapy
Kyung-Hee University, College of Pharmacy describes research in anaphylactic shock therapy
June 26th, 2007
Fresh data on anaphylactic shock are presented in the report "Inhibitory effect of schizandrin on passive cutaneous anaphylaxis reaction and scratching behaviors in mice." In this recent report, researchers in Seoul, Korea conducted a study "To evaluate the antiallergic effect of the fruit of Schizandra chinensis Baill (Family Magnoliaceae), which inhibited the mouse passive cutaneous anaphylaxis (PCA) reaction in a preliminary experiment, its main constituent, schizandrin, was isolated and its antiallergic effect investigated. Schizandrin inhibited the PCA reaction induced by the IgE-antigen complex, the scratching behaviors induced by compound 48/80 and the serum IgE production induced...
Source: Drug Law Weekly (2007-06-26)
|
